Switch to:
Also traded in: Germany, Mexico

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.07
COO's Cash-to-Debt is ranked lower than
96% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. COO: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
COO' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.08 Max: 2.39
Current: 0.07
0
2.39
Equity-to-Asset 0.52
COO's Equity-to-Asset is ranked lower than
66% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. COO: 0.52 )
Ranked among companies with meaningful Equity-to-Asset only.
COO' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.09  Med: 0.57 Max: 0.8
Current: 0.52
-0.09
0.8
Debt-to-Equity 0.71
COO's Debt-to-Equity is ranked higher than
50% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.37 vs. COO: 0.71 )
Ranked among companies with meaningful Debt-to-Equity only.
COO' s Debt-to-Equity Range Over the Past 10 Years
Min: -47.1  Med: 0.52 Max: 107.8
Current: 0.71
-47.1
107.8
Debt-to-EBITDA 3.60
COO's Debt-to-EBITDA is ranked lower than
74% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. COO: 3.60 )
Ranked among companies with meaningful Debt-to-EBITDA only.
COO' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.77  Med: 2.48 Max: 4.33
Current: 3.6
0.77
4.33
Interest Coverage 5.91
COO's Interest Coverage is ranked lower than
73% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. COO: 5.91 )
Ranked among companies with meaningful Interest Coverage only.
COO' s Interest Coverage Range Over the Past 10 Years
Min: 2.53  Med: 12.97 Max: 38.48
Current: 5.91
2.53
38.48
Piotroski F-Score: 6
Altman Z-Score: 3.90
Beneish M-Score: -2.84
WACC vs ROIC
8.35%
3.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 16.92
COO's Operating Margin % is ranked higher than
84% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. COO: 16.92 )
Ranked among companies with meaningful Operating Margin % only.
COO' s Operating Margin % Range Over the Past 10 Years
Min: 12.27  Med: 16.79 Max: 20.6
Current: 16.92
12.27
20.6
Net Margin % 5.23
COO's Net Margin % is ranked higher than
64% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. COO: 5.23 )
Ranked among companies with meaningful Net Margin % only.
COO' s Net Margin % Range Over the Past 10 Years
Min: 5.23  Med: 13.56 Max: 18.65
Current: 5.23
5.23
18.65
ROE % 4.03
COO's ROE % is ranked higher than
51% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. COO: 4.03 )
Ranked among companies with meaningful ROE % only.
COO' s ROE % Range Over the Past 10 Years
Min: 4.03  Med: 9.97 Max: 12.88
Current: 4.03
4.03
12.88
ROA % 2.24
COO's ROA % is ranked higher than
54% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. COO: 2.24 )
Ranked among companies with meaningful ROA % only.
COO' s ROA % Range Over the Past 10 Years
Min: 2.24  Med: 6.47 Max: 9.74
Current: 2.24
2.24
9.74
ROC (Joel Greenblatt) % 24.94
COO's ROC (Joel Greenblatt) % is ranked higher than
74% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. COO: 24.94 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
COO' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 14.16  Med: 22.71 Max: 30.54
Current: 24.94
14.16
30.54
3-Year Revenue Growth Rate 7.10
COO's 3-Year Revenue Growth Rate is ranked higher than
61% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. COO: 7.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
COO' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -62.6  Med: 8.4 Max: 30.8
Current: 7.1
-62.6
30.8
3-Year EBITDA Growth Rate 11.10
COO's 3-Year EBITDA Growth Rate is ranked higher than
54% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. COO: 11.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
COO' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.6 Max: 74.2
Current: 11.1
0
74.2
3-Year EPS without NRI Growth Rate 10.90
COO's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. COO: 10.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
COO' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 9.1 Max: 623.7
Current: 10.9
0
623.7
GuruFocus has detected 7 Warning Signs with The Cooper Companies Inc COO.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» COO's 30-Y Financials

Financials (Next Earnings Date: 2018-12-07 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

COO Guru Trades in Q3 2017

Ray Dalio 2,293 sh (New)
Steven Cohen 9,116 sh (New)
Jim Simons 207,400 sh (+49.75%)
Pioneer Investments 1,252,938 sh (+2.18%)
Mario Gabelli 24,000 sh (unchged)
Ron Baron 254,341 sh (unchged)
Ronald Muhlenkamp Sold Out
Ken Fisher 120,689 sh (-1.07%)
David Carlson 145,000 sh (-12.12%)
Joel Greenblatt 3,549 sh (-16.45%)
Caxton Associates 1,900 sh (-20.83%)
Eaton Vance Worldwide Health Sciences Fund 51,375 sh (-40.13%)
» More
Q4 2017

COO Guru Trades in Q4 2017

George Soros 2,500 sh (New)
Joel Greenblatt 46,121 sh (+1199.55%)
Caxton Associates 4,445 sh (+133.95%)
Jim Simons 422,848 sh (+103.88%)
Pioneer Investments 1,379,094 sh (+10.07%)
David Carlson 155,000 sh (+6.90%)
Mario Gabelli 24,000 sh (unchged)
Ray Dalio Sold Out
Steven Cohen Sold Out
Ken Fisher 115,080 sh (-4.65%)
Ron Baron 221,941 sh (-12.74%)
Eaton Vance Worldwide Health Sciences Fund 33,515 sh (-34.76%)
» More
Q1 2018

COO Guru Trades in Q1 2018

Ray Dalio 9,865 sh (New)
Steven Cohen 228,117 sh (New)
David Carlson 265,000 sh (+70.97%)
Mario Gabelli 25,000 sh (+4.17%)
Caxton Associates Sold Out
Joel Greenblatt Sold Out
George Soros Sold Out
Eaton Vance Worldwide Health Sciences Fund Sold Out
Ken Fisher 107,868 sh (-6.27%)
Ron Baron 183,628 sh (-17.26%)
Pioneer Investments 1,054,502 sh (-23.54%)
Jim Simons 138,098 sh (-67.34%)
» More
Q2 2018

COO Guru Trades in Q2 2018

Paul Tudor Jones 873 sh (New)
David Carlson 295,000 sh (+11.32%)
Mario Gabelli 25,000 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Pioneer Investments 1,035,668 sh (-1.79%)
Ken Fisher 103,849 sh (-3.73%)
Ron Baron 167,779 sh (-8.63%)
Ray Dalio 2,358 sh (-76.10%)
» More
» Details

Insider Trades

Latest Guru Trades with COO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Ron Baron 2018-06-30 Reduce -8.63%0.02%$217.98 - $237.23 $ 268.9318%167,779
Ken Fisher 2018-06-30 Reduce -3.73%$217.98 - $237.23 $ 268.9318%103,849
Ron Baron 2018-03-31 Reduce -17.26%0.04%$218.74 - $251.43 $ 268.9315%183,628
Ken Fisher 2018-03-31 Reduce -6.27%$218.74 - $251.43 $ 268.9315%107,868
Mario Gabelli 2018-03-31 Add 4.17%$218.74 - $251.43 $ 268.9315%25,000
Joel Greenblatt 2018-03-31 Sold Out 0.15%$218.74 - $251.43 $ 268.9315%0
George Soros 2018-03-31 Sold Out 0.02%$218.74 - $251.43 $ 268.9315%0
Ron Baron 2017-12-31 Reduce -12.74%0.04%$217.88 - $244.43 $ 268.9315%221,941
Ken Fisher 2017-12-31 Reduce -4.65%$217.88 - $244.43 $ 268.9315%115,080
Joel Greenblatt 2017-12-31 Add 1199.55%0.14%$217.88 - $244.43 $ 268.9315%46,121
George Soros 2017-12-31 New Buy0.02%$217.88 - $244.43 $ 268.9315%2,500
Ken Fisher 2017-09-30 Reduce -1.07%$231.6 - $254.9 $ 268.9310%120,689
Joel Greenblatt 2017-09-30 Reduce -16.45%$231.6 - $254.9 $ 268.9310%3,549
Ronald Muhlenkamp 2017-09-30 Sold Out 0.01%$231.6 - $254.9 $ 268.9310%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339115    SIC: 3841
Compare:NAS:XRAY, XSWX:STMN, NAS:HOLX, TSE:7733, NYSE:RMD, NYSE:MTD, NYSE:STE, NYSE:WAT, SZSE:002294, NYSE:WST, NYSE:HRC, NAS:ICUI, NAS:PODD, NYSE:CMD, TSE:7747, OCSE:COLO B, NYSE:HAE, MIL:AMP, OSTO:LIFCO B, ASX:ANN » details
Traded in other countries:CP6.Germany, COO.Mexico,
Headquarter Location:USA
The Cooper Companies Inc is a medical device company operating through its subsidiaries. It manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare.

Cooper Companies operates two units: CooperVision and CooperSurgical. Accounting for over 80% of total sales, CooperVision is one of the world's top four developers and manufacturers of contact lenses. Over 50% of CooperVision's sales are in international territories. At roughly 20% of total sales, CooperSurgical develops and manufactures diagnostic and surgical products for gynecologists and obstetricians.

Ratios

vs
industry
vs
history
PE Ratio 105.88
COO's PE Ratio is ranked lower than
86% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. COO: 105.88 )
Ranked among companies with meaningful PE Ratio only.
COO' s PE Ratio Range Over the Past 10 Years
Min: 8.06  Med: 22.6 Max: 1011.75
Current: 105.88
8.06
1011.75
Forward PE Ratio 22.27
COO's Forward PE Ratio is ranked higher than
67% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. COO: 22.27 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 105.88
COO's PE Ratio without NRI is ranked lower than
86% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. COO: 105.88 )
Ranked among companies with meaningful PE Ratio without NRI only.
COO' s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.06  Med: 22.6 Max: 1011.75
Current: 105.88
8.06
1011.75
Price-to-Owner-Earnings 62.95
COO's Price-to-Owner-Earnings is ranked lower than
52% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. COO: 62.95 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
COO' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.32  Med: 24.13 Max: 195
Current: 62.95
13.32
195
PB Ratio 4.09
COO's PB Ratio is ranked lower than
57% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. COO: 4.09 )
Ranked among companies with meaningful PB Ratio only.
COO' s PB Ratio Range Over the Past 10 Years
Min: 0.37  Med: 2.26 Max: 4.09
Current: 4.09
0.37
4.09
PS Ratio 5.45
COO's PS Ratio is ranked lower than
67% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. COO: 5.45 )
Ranked among companies with meaningful PS Ratio only.
COO' s PS Ratio Range Over the Past 10 Years
Min: 0.51  Med: 3.43 Max: 5.93
Current: 5.45
0.51
5.93
Price-to-Free-Cash-Flow 29.80
COO's Price-to-Free-Cash-Flow is ranked higher than
58% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. COO: 29.80 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
COO' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.35  Med: 25.1 Max: 108.32
Current: 29.8
7.35
108.32
Price-to-Operating-Cash-Flow 21.17
COO's Price-to-Operating-Cash-Flow is ranked higher than
51% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. COO: 21.17 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
COO' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.53  Med: 15.34 Max: 24.41
Current: 21.17
5.53
24.41
EV-to-EBIT 39.80
COO's EV-to-EBIT is ranked lower than
71% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. COO: 39.80 )
Ranked among companies with meaningful EV-to-EBIT only.
COO' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.2  Med: 21.3 Max: 56.4
Current: 39.8
11.2
56.4
EV-to-EBITDA 24.08
COO's EV-to-EBITDA is ranked lower than
57% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. COO: 24.08 )
Ranked among companies with meaningful EV-to-EBITDA only.
COO' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.8  Med: 14.9 Max: 24.3
Current: 24.08
6.8
24.3
EV-to-Revenue 6.29
COO's EV-to-Revenue is ranked lower than
69% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. COO: 6.29 )
Ranked among companies with meaningful EV-to-Revenue only.
COO' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.4  Med: 3.7 Max: 6.5
Current: 6.29
1.4
6.5
PEG Ratio 13.75
COO's PEG Ratio is ranked lower than
65% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. COO: 13.75 )
Ranked among companies with meaningful PEG Ratio only.
COO' s PEG Ratio Range Over the Past 10 Years
Min: 0.85  Med: 4.48 Max: 189
Current: 13.75
0.85
189
Shiller PE Ratio 57.41
COO's Shiller PE Ratio is ranked lower than
52% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.97 vs. COO: 57.41 )
Ranked among companies with meaningful Shiller PE Ratio only.
COO' s Shiller PE Ratio Range Over the Past 10 Years
Min: 7.16  Med: 39.86 Max: 60.08
Current: 57.41
7.16
60.08
Current Ratio 2.58
COO's Current Ratio is ranked lower than
55% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. COO: 2.58 )
Ranked among companies with meaningful Current Ratio only.
COO' s Current Ratio Range Over the Past 10 Years
Min: 0.86  Med: 2.18 Max: 4.36
Current: 2.58
0.86
4.36
Quick Ratio 1.54
COO's Quick Ratio is ranked lower than
69% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. COO: 1.54 )
Ranked among companies with meaningful Quick Ratio only.
COO' s Quick Ratio Range Over the Past 10 Years
Min: 0.6  Med: 1.25 Max: 4.19
Current: 1.54
0.6
4.19
Days Inventory 197.37
COO's Days Inventory is ranked lower than
74% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. COO: 197.37 )
Ranked among companies with meaningful Days Inventory only.
COO' s Days Inventory Range Over the Past 10 Years
Min: 167.05  Med: 203.22 Max: 230.08
Current: 197.37
167.05
230.08
Days Sales Outstanding 56.12
COO's Days Sales Outstanding is ranked lower than
57% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. COO: 56.12 )
Ranked among companies with meaningful Days Sales Outstanding only.
COO' s Days Sales Outstanding Range Over the Past 10 Years
Min: 52.77  Med: 57.61 Max: 62.22
Current: 56.12
52.77
62.22
Days Payable 49.70
COO's Days Payable is ranked higher than
61% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. COO: 49.70 )
Ranked among companies with meaningful Days Payable only.
COO' s Days Payable Range Over the Past 10 Years
Min: 27.82  Med: 55.91 Max: 70.39
Current: 49.7
27.82
70.39

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.02
COO's Dividend Yield % is ranked lower than
100% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.16 vs. COO: 0.02 )
Ranked among companies with meaningful Dividend Yield % only.
COO' s Dividend Yield % Range Over the Past 10 Years
Min: 0.02  Med: 0.06 Max: 0.52
Current: 0.02
0.02
0.52
Dividend Payout Ratio 0.02
COO's Dividend Payout Ratio is ranked higher than
99% of the 100 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.31 vs. COO: 0.02 )
Ranked among companies with meaningful Dividend Payout Ratio only.
COO' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.01 Max: 0.04
Current: 0.02
0.01
0.04
Forward Dividend Yield % 0.02
COO's Forward Dividend Yield % is ranked lower than
100% of the 161 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.30 vs. COO: 0.02 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.02
COO's 5-Year Yield-on-Cost % is ranked lower than
100% of the 209 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. COO: 0.02 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
COO' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.02  Med: 0.06 Max: 0.52
Current: 0.02
0.02
0.52
3-Year Average Share Buyback Ratio -0.50
COO's 3-Year Average Share Buyback Ratio is ranked higher than
73% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -5.00 vs. COO: -0.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
COO' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -12.9  Med: -2.5 Max: 1.2
Current: -0.5
-12.9
1.2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.13
COO's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
57% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. COO: 2.13 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
COO' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.54  Med: 1.69 Max: 10.94
Current: 2.13
0.54
10.94
Price-to-Intrinsic-Value-DCF (Earnings Based) 9.89
COO's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
87% of the 23 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. COO: 9.89 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
COO' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.98  Med: 2.05 Max: 81.4
Current: 9.89
0.98
81.4
Price-to-Median-PS-Value 1.59
COO's Price-to-Median-PS-Value is ranked lower than
81% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. COO: 1.59 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
COO' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.04  Med: 0.76 Max: 2.12
Current: 1.59
0.04
2.12
Price-to-Peter-Lynch-Fair-Value 12.67
COO's Price-to-Peter-Lynch-Fair-Value is ranked lower than
82% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. COO: 12.67 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
COO' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.67  Med: 1.5 Max: 129.63
Current: 12.67
0.67
129.63
Earnings Yield (Greenblatt) % 2.51
COO's Earnings Yield (Greenblatt) % is ranked higher than
58% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. COO: 2.51 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
COO' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.8  Med: 4.7 Max: 8.9
Current: 2.51
1.8
8.9
Forward Rate of Return (Yacktman) % 10.67
COO's Forward Rate of Return (Yacktman) % is ranked lower than
51% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.66 vs. COO: 10.67 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
COO' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -0.6  Med: 9.8 Max: 21.5
Current: 10.67
-0.6
21.5

More Statistics

Revenue (TTM) (Mil) $2,442.80
EPS (TTM) $ 2.54
Beta0.97
Volatility21.99%
52-Week Range $216.47 - 270.64
Shares Outstanding (Mil)49.14

Analyst Estimate

Oct18 Oct19
Revenue (Mil $) 2,525 2,676
EBIT (Mil $) 457 622
EBITDA (Mil $) 733 903
EPS ($) 7.10 9.75
EPS without NRI ($) 7.10 9.75
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.70%
Dividends per Share ($) 0.06 0.06

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyN
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}